GPT and metabolic dysfunction-associated steatohepatitis: As shown in Table 2, we found that patients in the NASH group experienced a significantly greater reduction in ALT (p < 0.001), AST (p < 0.001), glycemia (p < 0.001), fasting insulinemia (p = 0.014), and Homa-IR (p = 0.001).